D.E. Shaw & Co’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

D.E. Shaw & Co’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-786,795	Closed	-$8.09M	–	5079
2022 Q4	$8.09M	Buy	786,795 +1,000	+0.1%	+$10.2K	0.01%	1636
2022 Q3	$7.91M	Buy	785,795 +612	+0.1%	+$6.15K	0.01%	1575
2022 Q2	$7.87M	Buy	785,183 +275,132	+54%	+$2.75M	0.01%	1628
2022 Q1	$5.1M	Buy	510,051 +410,051	+410%	+$4.07M	﹤0.01%	2285
2021 Q4	$990K	Buy	+100,000	New	+$988K	﹤0.01%	3933

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

D.E. Shaw & Co's IQMD Position: Q1 2023 in Review

D.E. Shaw & Co sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 786,795 shares — an estimated $8.09M sold.

D.E. Shaw & Co first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $8.09M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

D.E. Shaw & Co reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
D.E. Shaw & Co sold 786,795 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $8.09M.
D.E. Shaw & Co first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
D.E. Shaw & Co's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $8.09M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.